Sign In
Buy IDXX
$560.73
+9.91 (+1.80%)
At Close: Jun 03, 2026
IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel Conference
07:02am, Saturday, 30'th May 2026
IDEXX Laboratories NASDAQ: IDXX President and CEO Michael Erickson used a Stifel investor conference appearance to emphasize the company's innovation pipeline, expanding commercial reach and growing u
IDEXX Laboratories, Inc. (IDXX) Presents at Stifel Jaws & Paws Conference 2026 Transcript
01:27pm, Wednesday, 27'th May 2026
IDEXX Laboratories, Inc. (IDXX) Presents at Stifel Jaws & Paws Conference 2026 Transcript
IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection
07:00am, Tuesday, 26'th May 2026
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX expands Fecal Dx™ antigen testing with taeniid tapeworm detection for broader intestinal parasite screening in wellness and sick-pet care.
IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles
07:00am, Tuesday, 19'th May 2026
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX integrates SDMA into most common Catalyst chemistry profiles, enabling earlier detection of kidney disease through routine in‑clinic testing.
The Biology Came First.
09:00am, Monday, 18'th May 2026
MindWalk Holdings Corp. (NASDAQ: HYFT) today released a systematic report identifying over 20 discovery-originated drug candidates with documented origins in a
IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day
04:34pm, Thursday, 14'th May 2026
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Mike Erickson, President and Chief Executive Officer, wil
IDEXX Laboratories Inc (IDXX) Shares Fall 5.0% -- What GF Score of 99 Tells Investors
07:52pm, Monday, 11'th May 2026
On May 11, 2026, IDEXX Laboratories Inc (IDXX) shares fell 5.0% to a current price of $532.00. This decline comes amid a challenging performance period for the
IDEXX Laboratories, Inc. (IDXX) Q1 2026 Earnings Call Transcript
02:11pm, Tuesday, 05'th May 2026
IDEXX Laboratories, Inc. (IDXX) Q1 2026 Earnings Call Transcript
IDEXX Stock Up on Q1 Earnings & Revenue Beat, Margins Rise, '26 View Up
11:31am, Tuesday, 05'th May 2026
IDXX rides strong on Q1 beats with rising margins; lifts 2026 outlook as diagnostics growth and innovation momentum fuel performance.
Idexx (IDXX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
10:30am, Tuesday, 05'th May 2026
The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Idexx Laboratories Raises Guidance On Higher Clinical Visits, Diagnostic Frequency
10:20am, Tuesday, 05'th May 2026
Idexx Laboratories Inc (NASDAQ:IDXX) shares are up on Tuesday as the company recently announced strong first-quarter results, showcasing a 14% revenue growth.
Idexx Laboratories (IDXX) Q1 Earnings and Revenues Surpass Estimates
08:45am, Tuesday, 05'th May 2026
Idexx Laboratories (IDXX) came out with quarterly earnings of $3.47 per share, beating the Zacks Consensus Estimate of $3.42 per share. This compares to earnings of $2.96 per share a year ago.
IDEXX Laboratories Announces First Quarter Results
06:30am, Tuesday, 05'th May 2026
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results. First Quarter Results The Company repor
GMED vs. IDXX: Which Stock Should Value Investors Buy Now?
12:40pm, Monday, 04'th May 2026
Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED) and Idexx Laboratories (IDXX). But which of these two stocks is more attractive to value investors?
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:55am, Monday, 04'th May 2026
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
